text: <unk>  is an antiemetic, neurokinin-1 receptor antagonist that is FDA approved for the prophylaxis of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin and nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC). Its also, indicated for the prevention of postoperative nausea and vomiting (PONV).   Common adverse reactions include alopecia, anorexia, asthenia/fatigue, constipation, diarrhea, headache, hiccups, nausea, hypotension, pruritus, pyrexia.
option_0: Aprepitant
option_1: Eptifibatide
option_2: Iofendylate
option_3: Oprelvekin
option_4: Prasugrel
option_5: Bepotastine Besilate
option_6: Defibrotide
option_7: Ambrisentan